HIGHLIGHTS
- who: from the Harnessing tumorous flaws for immune supremacy: is mi, the weak link in breast cancer progression? Samantha Sharma [1] Mateusz Opyrchal, , and Xiongbin Lu1, Department of Medical and Molecular Genetics and Department of Medicine, Division of Hematology/Oncology, Indiana University School of Medicine, Indianapolis, Indiana, USA Indiana University have published the research work: Harnessing tumorous flaws for immune supremacy: is miRNA-155 the weak link in breast cancer progression?, in the Journal: (JOURNAL)
- how: These data indicated that miR-155 is important in regulating tumor progression and its overexpression results in decreased tumor . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.